Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Sign Up to like & getrecommendations! Published in 2022 at "Molecular cancer therapeutics"
DOI: 10.1158/1538-7445.am2022-4005
Abstract: Management of hepatoblastoma (HB), the most frequent pediatric liver cancer, is based on surgical resection and perioperative chemotherapy regimens. In this study, we aimed to identify actionable targets in HB and assess the efficacy of… read more here.
Keywords: driver; igf2 overexpression; hepatoblastoma; combination ... See more keywords